Zuprevo_PI HR.pdf 1 10/10/14 3:51 PM
CATTLE RAISERS COMMUNITY
PRODUCT INFORMATION NADA 141-334, Approved by FDA.
18% 048539 R10 INDUSTRY ALLIED
Injectable Solution for Cattle ANTIMICROBIAL DRUG
180 mg of tildipirosin/mL For subcutaneous injection in beef and non-lactating dairy cattleonly.
Not for use in female dairy cattle 20 months of age or older or in calves to be processed for veal.
CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensedveterinarian.
BRIEF SUMMARY: for full prescribing information use package insert.
INDICATIONS: Zuprevo 18% is indicated for the treatmentof bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in beef and non-lactatingdairy cattle, and for the control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with M.haemolytica, P. multocida, and H. somni.
™
WARNINGS: FOR USE IN ANIMALS ONLY. NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. TO AVOID ACCIDENTAL INJECTION, DO NOT USE IN AUTOMATICALLY POWERED SYRINGES WHICH HAVE NO ADDITIONAL PROTECTION SYSTEM. IN CASE OF HUMAN INJECTION, SEEK MEDICAL ADVICE IMMEDIATELY AND SHOW THE PACKAGE INSERT OR LABEL TO THE PHYSICIAN.
Avoid direct contact with skin and eyes. If accidental eye exposure occurs, rinse eyes with clean water. If accidental skin exposure occurs, wash the skin immediately with soap and water. Tildipirosin may cause sensitization by skin contact.
For technical assistance or to report a suspected adverse reaction, call: 1-800-219-9286.
For customer service or to request a Material Safety Data Sheet (MSDS), call: 1-800-211-3573. For additional Zuprevo 18% information go to
www.zuprevo.com.
For a complete listing of adverse reactions for Zuprevo 18% reported to CVM see:
http://www.fda.gov/AnimalVeterinary/SafetyHealth.
DO NOT USE ZUPREVO 18% IN SWINE. Fatal adverse events have been reported following the use of tildipirosin in swine. NOT FOR USE IN CHICKENS OR TURKEYS.
RESIDUE WARNING: Cattle intended for human consumption must not be slaughtered within 21 days of the last treatment. Do not use in female dairy cattle 20 months of age or older. Use of this drug product in these cattle may cause milk residues. A withdrawal period has not been established in pre- ruminating calves. Do not use in calves to be processed for veal.
PRECAUTIONS: The effects of Zuprevo 18% on bovine reproductive performance, pregnancy and lactation have not been determined. Swelling and inflammation, which may be severe, may be seen at the injection site after administration. Subcutaneous injection may result in local tissue reactions which persist beyond the slaughter withdrawal period. This may result in trim loss of edible tissue at slaughter.
Made in Germany
Distributed by: Intervet Inc d/b/a Merck Animal Health, Summit, NJ 07901 Copyright © 2011, Intervet Inc., a subsidiary
of Merck & Co. All rights reserved.
Four Reasons Preconditioning Makes ‘Cents’
Cow/calf producers can add signifi cant value by implementing a preconditioning program, which can pay off all the way through to the feedlot.
I
T IS COMMON FOR PRODUCERS TO WANT TO CAPITALIZE ON TIMES OF HIGH CATTLE PRICES as quickly as possible, and it is no different for the valuable calf crop this
year. Producers are gearing up to cash in on their investment in produc- ing and raising a healthy calf but there are a few reasons to slow down and evaluate whether this is the most profi table path. Could waiting a few months longer realize additional payoff? “Preconditioning calves is one way that a farm or ranch can really add
value, whether those cattle are staying on the farm or moving into a stocker or feedlot scenario,” says Chris Forcherio, Ph.D., beef research manager at the Purina Animal Nutrition Center. “The producer implementing a preconditioning program may receive a higher premium and no matter where the calf goes after that, the opportunity for improved health and performance should be adding value from that program.” Preconditioning, which commonly includes a vaccination, nutritional
and management program to help calves through a stressful timeframe, can be an investment, but it can be an investment with potentially bigger payoffs down the road. Here are 4 reasons preconditioning makes ‘cents’:
1. Improved health As many producers know, weaning can be a very stressful time for
calves. Stress may cause them to go off feed, become immunocompromised and more susceptible to disease, or even result in death. “Calves that are preconditioned with an effective vaccination program
and started on a high-quality nutrition program may be better equipped to handle this period of stress,” says Forcherio. Research shows that preconditioned calves may have a signifi cant
reduction in treatment costs, as much as $29.50 per head, as well as 3.1 percent lower mortality rate in comparison to non-preconditioned calves. Investing in animal health with preconditioning can help cattle get through a stressful period with potentially less treatment cost and more calves down the road.
2. Additional weight gain and increased feed effi ciency Selling calves later, after going through a preconditioning program
(45 days or more), will have added weight versus calves that are sold at weaning. Additionally, research shows that preconditioned calves have 7.2 percent better feed effi ciency.
MORE
TC-53715_Stock_FP_8-15-NY.indd 2 30 The Cattleman October 2015 7/14/15 1:30 PM
thecattlemanmagazine.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148